<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Amnog-Nice-Submission-Workflow on Bioecon</title><link>https://en.bioecon.ru/technologies/amnog-nice-submission-workflow/</link><description>Recent content in Amnog-Nice-Submission-Workflow on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 10 Aug 2026 22:40:14 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/amnog-nice-submission-workflow/index.xml" rel="self" type="application/rss+xml"/><item><title>HTA dossier preparation</title><link>https://en.bioecon.ru/technology/hta-dossier-preparation/</link><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/hta-dossier-preparation/</guid><description>Health-economic evidence packages — systematic clinical-evidence reviews, cost-effectiveness and budget-impact modeling, patient-perspective data — that a biopharma manufacturer must assemble to win pricing and reimbursement approval from a national HTA body (NICE, G-BA, CADTH), prepared by specialty consultancies against strict statutory deadlines (56 days for a NICE Single Technology Appraisal), increasingly using AI to compress a traditionally months-long process.</description></item></channel></rss>